NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis

NYSE:NUS • US67018T1051

7.56 USD
-0.52 (-6.44%)
At close: Mar 3, 2026
7.56 USD
0 (0%)
After Hours: 3/3/2026, 6:40:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. NUS has an average financial health and profitability rating. NUS is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • NUS had positive earnings in the past year.
  • NUS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NUS reported negative net income in multiple years.
  • Of the past 5 years NUS 4 years had a positive operating cash flow.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.69%, NUS is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.70%, NUS belongs to the top of the industry, outperforming 81.08% of the companies in the same industry.
  • NUS's Return On Invested Capital of 4.08% is in line compared to the rest of the industry. NUS outperforms 56.76% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 11.10%.
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROIC 4.08%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

  • NUS's Profit Margin of 7.02% is fine compared to the rest of the industry. NUS outperforms 75.68% of its industry peers.
  • NUS has a Operating Margin (3.87%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of NUS has declined.
  • NUS's Gross Margin of 67.20% is in line compared to the rest of the industry. NUS outperforms 54.05% of its industry peers.
  • In the last couple of years the Gross Margin of NUS has declined.
Industry RankSector Rank
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
  • NUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.68 indicates that NUS is not in any danger for bankruptcy at the moment.
  • NUS has a Altman-Z score of 3.68. This is in the better half of the industry: NUS outperforms 78.38% of its industry peers.
  • NUS has a debt to FCF ratio of 4.29. This is a neutral value as NUS would need 4.29 years to pay back of all of its debts.
  • NUS's Debt to FCF ratio of 4.29 is fine compared to the rest of the industry. NUS outperforms 75.68% of its industry peers.
  • A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
  • The Debt to Equity ratio of NUS (0.26) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Altman-Z 3.68
ROIC/WACC0.51
WACC8.04%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
  • NUS's Current ratio of 2.15 is in line compared to the rest of the industry. NUS outperforms 51.35% of its industry peers.
  • NUS has a Quick Ratio of 1.45. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of NUS (1.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.45
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
  • Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.78% on average per year.
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 1.05% on average over the next years.
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.86 indicates a rather cheap valuation of NUS.
  • Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (26.83), we can say NUS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 5.27, the valuation of NUS can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.89% of the companies listed in the same industry.
  • NUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.86
Fwd PE 5.27
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaper than 100.00% of the companies in the same industry.
  • 91.89% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.91
EV/EBITDA 3.17
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • NUS has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of NUS has falen by -24.25%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.61, NUS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, NUS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

  • The dividend of NUS decreases each year by -30.50%.
  • NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 10.87% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP10.87%
EPS Next 2YN/A
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NU SKIN ENTERPRISES INC - A

NYSE:NUS (3/3/2026, 6:40:00 PM)

After market: 7.56 0 (0%)

7.56

-0.52 (-6.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners77.1%
Inst Owner Change1.2%
Ins Owners2.11%
Ins Owner Change11.94%
Market Cap368.55M
Revenue(TTM)N/A
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %4.26%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 5.86
Fwd PE 5.27
P/S 0.24
P/FCF 6.91
P/OCF 4.12
P/B 0.46
P/tB 0.55
EV/EBITDA 3.17
EPS(TTM)1.29
EY17.06%
EPS(NY)1.43
Fwd EY18.97%
FCF(TTM)1.09
FCFY14.48%
OCF(TTM)1.83
OCFY24.27%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.52
PEG (5Y)N/A
Graham Number21.82
Profitability
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROCE 5.16%
ROIC 4.08%
ROICexc 5.21%
ROICexgc 6.05%
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
FCFM 3.42%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Debt/EBITDA 1.8
Cap/Depr 64.7%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 76.96%
Profit Quality 48.67%
Current Ratio 2.15
Quick Ratio 1.45
Altman-Z 3.68
F-Score6
WACC8.04%
ROIC/WACC0.51
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%

NU SKIN ENTERPRISES INC - A / NUS FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NUS stock?

The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 5.86 and the Price/Book (PB) ratio is 0.46.


Can you provide the dividend sustainability for NUS stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 10.87%.